Skip to content
An Initiative of AVAC In partnership with Access Bridge
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 11 - 20 of 430

Selected Filters:
18 June 2026

UNAIDS Global AIDS Brief: United to End AIDS

This report from UNAIDS outlines how external funding cuts, a strong push back on human rights, and under investment and under prioritization of HIV prevention and community services are threatening to reverse years of gains in the AIDS response.

Monitoring & Evaluation, Research, Service Delivery

External Link
16 June 2026

Advocates’ Primer: Understanding Bioequivalence and Pharmacokinetic Studies in Next-Generation HIV Prevention Products

As more next-generation PrEP options become available, HIV prevention research is shifting away from large, multi-year efficacy trials toward pharmacokinetic (PK) and bioequivalence (BE) studies — which test whether a new formulation behaves in the body like a product already proven to work. This primer explains the shift and what it means for advocates.

Community/Advocacy, Research

External Link
5 June 2026

Long-Acting PrEP for People With High Vulnerability to HIV Acquisition in Brazil: A cost-effectiveness analysis

This article from Journal of the International AIDS Society assesses the potential clinical and economic impact of offering injectable cabotegravir or lenacapavir to gay and bisexual men who have sex with men and transgender women with high vulnerability to HIV acquisition in Brazil and determines the maximum cost at which they would be cost-effective.

Financing & Costing, Research

External Link
8 May 2026

PrEP Drug Interaction Checker

This website, developed and maintained by the University of Liverpool, provides clear, trustworthy, and up-to-date information about how different PrEP options, including oral PrEP, cabotegravir, lenacapavir, and the dapivirine vaginal ring, can interact with other drugs.

Research, Service Delivery

External Link
26 February 2026

Early Experiences with Usage of Long-acting Injectable Cabotegravir among Adults in Rural Ugandan and Kenyan Communities: Qualitative research from the SEARCH “Dynamic Choice HIV Prevention” intervention trials

This article from Journal of the International AIDS Society describes the results of a qualitative study exploring experiences with injectable cabotegravir (CAB for PrEP) among adults participating in the SEARCH Dynamic Choice HIV Prevention (DCP) trial in rural Kenya and Uganda, which evaluated HIV prevention uptake through a structured, person-centred DCP model.

Community/Advocacy, Research, Service Delivery

External Link
9 February 2026

Dapivirine Ring: Giving Women Hope and Choice in HIV Prevention

Recording / Transcript / Slides / Resources The monthly Dapivirine Vaginal Ring (DVR) is a critical option in the HIV prevention toolkit, being entirely woman controlled, discrete, and very safe and simple to implement. This webinar will highlight ongoing Market Access activities to ensure women have access to the monthly DVR; key learnings from community…

Community/Advocacy, Research, Service Delivery

Event
13 January 2026

Integrated Study Dashboard

This dashboard, produced under the BioPIC project, reflects all currently known activities relating to implementation research, modelling, clinical research, and landscaping for new late stage biomedical HIV PrEP options, including lenacapavir for PrEP, cabotegravir, and the dapivirine vaginal ring. To update or add any activities missing from the dashboard, or if you have questions on…

Research

External Link
6 January 2026

Country Planning for Product Introduction Matrix

AVAC’s Country Planning for Product Introduction Matrix tracks key indicators for the introduction of new PrEP products, including lenacapavir (LEN), cabotegravir (CAB), and the Dapivirine Vaginal Ring (DVR), by country, including regulatory status, late stage clinical trials and implementation research, procurement plans, and recent oral PrEP provision.

Research, Service Delivery

External Link
26 November 2025

A Dual Prevention Pill for HIV & Pregnancy Prevention: A pilot study among adolescent girls and young women in Zimbabwe

This article from AIDS and Behavior describes the results of a study examining whether an over-encapsulated dual prevention pill (DPP) combining PrEP + oral contraceptive would be preferred, acceptable, and improve adherence compared to PrEP alone amongst adolescent girls and young women in Zimbabwe.

Research

External Link
21 November 2025

Women’s Preferences for Integrating Multi-product Pre-exposure Prophylaxis Delivery Programs within Services for Sexually Transmitted Infections and Reproductive Health Care in Uganda: A discrete choice experiment

This article from Frontiers in Reproductive Health describes the results of a cross-sectional discrete choice experiment to determine the most preferred attributes and levels of multi-product PrEP programs for adolescent girls and young women in Uganda.

Research, Service Delivery

External Link